Cargando…
A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer
Lung cancer remains the leading cause of cancer deaths worldwide. Although low-dose spiral computed tomography (LDCT) screening is used for the detection of lung cancer in a high-risk population, false-positive results of LDCT remain a clinical problem. Here, we developed a blood test of a novel pan...
Autores principales: | Wei, Bing, Wu, Fengxin, Xing, Wenqun, Sun, Haibo, Yan, Chi, Zhao, Chengzhi, Wang, Dongqing, Chen, Xiaobing, Chen, Yanli, Li, Mingming, Ma, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373977/ https://www.ncbi.nlm.nih.gov/pubmed/34408226 http://dx.doi.org/10.1038/s41598-021-96242-6 |
Ejemplares similares
-
A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules
por: Xing, Wenqun, et al.
Publicado: (2021) -
A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
por: Shen, Nan, et al.
Publicado: (2019) -
A Panel of DNA Methylation and Proteomic Biomarkers for Specific Aging Pathways
por: Higgins-Chen, Albert, et al.
Publicado: (2020) -
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity
por: Zang, Ruochuan, et al.
Publicado: (2019) -
Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers
por: Hu, Shuo, et al.
Publicado: (2023)